Back to top

Iovance Biotherapeutics (IOVA) Jumps: Stock Rises 5.1%

Read MoreHide Full Article

Iovance Biotherapeutics, Inc. (IOVA - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 11.8% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Iovance Biotherapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the Medical - Biomedical and Genetics industry may consider Illumina, Inc. (ILMN - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is IOVA going up? Or down? Predict to see what others think:Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>
 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Illumina, Inc. (ILMN) - free report >>

Lion Biotechnologies, Inc. (IOVA) - free report >>

More from Zacks Tale of the Tape

You May Like